Due to decided scope of the report, nontherapeutic synthetic cannabinoids will not be discussed from the forthcoming chapters in the report.The US’ cannabis analysis bill, passed into law in December 2022, is expected that will help ease some of the concerns in working with cannabis and cannabinoids within the lab.With all this operate underway o